Peripheral Vascular Disorders
Conference Coverage
DETOUR system shows early promise for long SFA lesions
Percutaneous treatment of long SFA lesions showed good patency, low rate of major adverse events.
Conference Coverage
Medtronic, others push forward with HTN renal artery denervation
SAN FRANCISCO – Despite its major 2014 trial failure, renal denervation is still a hot topic, with a new, successful catheter.
Conference Coverage
IN.PACT Global: Promising 2-year data for drug-coated balloon performance for femoropopliteal PAD
Drug-coated balloon shows promising 2-year results for treating fempop PAD.
From the Journals
Rheumatoid arthritis characteristics make large contribution to cardiovascular risk
RA characteristics had a larger effect on women’s risk than on men’s.
Conference Coverage
EVAR registry results show equivalence between the sexes
EVAR outcomes between the sexes were equivalent at 30 days and 1 through 5 years.
From the Journals
New data prompt update to ACC guidance on nonstatin LDL lowering
The ACC has updated its advice regarding the use of nonstatin therapies following clinical trial results of PCSK9 inhibitors and ezetimibe.
Conference Coverage
Older men benefit from vascular screening
BARCELONA – Vascular screening led to 7% lower mortality in older men compared, compared with controls.
From the Journals
Metabolically healthy obese still at elevated cardiovascular risk
Fat is not benign, according to a U.K. study of 3.5 million people.
Feature
Absorb bioresorbable scaffold folds
Abbott is no longer marketing the Absorb bioresorbable scaffold, citing poor sales.
News from the FDA/CDC
Recent upturn seen in stroke death rate
Long-term decline ended in 2013; reasons for the reversal “are not clear.”
Conference Coverage
VIDEO: Anacetrapib doubles HDL, but patients gain from its modest LDL cut
BARCELONA – Parsing the CTEP inhibitor’s means of conferring benefit proves elusive.